Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
Living with an “incurable” cancer since 1994 (Multiple Myeloma) and more than 10 years of cancer research have taught me that most cancers patients and survivors do not benefit from an all or nothing approach to cancer management. Treating multiple myeloma as well as other cancers is not strictly conventional/traditional or nonconventional/nontraditional- at least in my experience.
To be clear, HPV is “associated with” multiple myeloma. While studies confirm that HPV (warts) increases the risk of multiple myeloma, there is no discussion that HPV causes MM.
I never thought much about my warts. They never really bothered me much. However once I learned that HPV (warts) increases the risk of multiple myeloma (my cancer), and that AHCC has been shown to eradicate HPV, I decided to supplement with AHCC. While I’ll never know for certain if my AHCC supplementation eradicated my HPV, I have been in complete remission from my MM since 1999.
Active hexose correlated compound (AHCC) is one of a number of evidence-based, non-conventional therapies that can heal the MM patient. According to the articles linked and excerpted below AHCC is a nutritional supplement that can
Whether you undergo surgery to debulk a tumor, undergo toxic chemotherapy to treat your multiple myeloma and possibly weakening your immune system, you will benefit from evidence-based, non-conventional therapies.
Like curcumin, green tea extract, vitamin D3, milk thistle, grape seed extract, resveratrol and others, it is up to the cancer patient/survivor/caregiver to read studies and decide for him or herself if AHCC is right for their cancer situation.
I am a long-term multiple myeloma survivor and MM cancer coach. To learn more about how supplementation/nutriceuticals can support your health, scroll down the page, post a question or comment and I will reply to you ASAP.
“Active Hexose Correlated Compound (AHCC) is an alpha-glucan rich nutritional supplement produced from the mycelia of shiitake (Lentinula edodes) of the basidiomycete family of mushrooms, and is not an approved drug…AHCC was originally designed to lower high-blood pressure. However, researchers at Tokyo University found that AHCC increased natural killer (NK) cell activity in cancer patients, and also enhanced the effects of killer T-cells, and cytokines…”
“Treating cervical cancer cells with AHCC led to the eradication of HPV, human papillomavirus, as well as a decrease in the rate of tumor growth in-vitro and in-vivo…These data suggest AHCC can eliminate HPV infections and may have a role in the prevention of HPV-related cancers…According to the CDC several other types of cancer are also HPV related, including: 95% of anal cancer; 60% of oropharyngeal cancer; 65% of vaginal cancer; 50% of vulvar cancer; and 35% of penile cancer.
“A Japanese mushroom extract appears to be effective for the eradication of human papillomavirus (HPV), according to a pilot clinical trial. Ten HPV-positive women were treated orally with the extract, AHCC (active hexose correlated compound) once daily for up to six months. Five achieved a negative HPV test result — three with confirmed eradication after stopping AHCC — with the remaining two responders continuing on the study….”
“Recently, AHCC was found to improve the prognosis of hepatocellular carcinoma patients following surgical treatment. We investigated whether AHCC could prolong survival and improve the prognosis of patients with advanced liver cancer…Patients in the AHCC treated-group had a significantly prolonged survival when compared to the control group by Mann-Whitney test (95% CI, p = 0.000). Quality of life in terms of mental stability, general physical health status, and ability to have normal activities were significantly improved after 3 months of AHCC treatment when tested using the Wilcoxon signed-rank test..
This study suggests that AHCC intake could prolong the survival and improve the prognosis of patients with advanced liver cancer and delay the gradual decline of their physiological status.
“These findings suggest that salivary HHV-6 levels may be a good biomarker of QOL in patients during chemotherapy, and that AHCC may have a beneficial effect on chemotherapy-associated adverse effects and QOL in patients with cancer undergoing chemotherapy…”